The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Community Health Systems Inc. (CYH) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.11, or 2.50%, to $4.51. The Community Health Systems Inc. has recorded 20,651 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Community Health Systems Completes Divestiture of Hospital Located in Ronceverte, West Virginia.
The company is listed on the NYSE and operates within the Medical Care Facilities industry segment. At the end of the last regular session, the stock closed at $4.40 and fluctuated between $4.6750 as its day high and $4.3100 as its day low. The current market capitalization of Community Health Systems Inc. is $603.11M. A total of 2.95 million shares were traded on the day, compared to an average of 2.61M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, CYH has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 37 BUYs and 12 SELLs from insiders. Insiders purchased 2,415,018 shares during that period but sold 460,648.
In the most recent transaction, SMITH WAYNE T bought 800,000 shares of CYH for 2.94 per share on Aug 02. After the transaction, the Executive Chairman now owns 4,059,196 company shares. In a previous transaction on Aug 01, SMITH WAYNE T bought 200,000 shares at 3.00 per share. CYH shares that Executive Chairman owns now total 3,259,196.
Among the insiders who bought shares, Ely James S. III acquired of 10,000 shares on Jun 02 at a per-share price of $5.00. This resulted in the Director holding 301,299 shares of CYH after the transaction. In another insider transaction, Ely James S. III bought 30,000 shares at $5.09 per share on Jun 01. Company shares held by the Director now total 291,299.
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. CYH’s most recent ex-dividend date was 12/13/2012 when it declared a $0.25 quarterly dividend that was paid in cash on 12/28/2012.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for CYH in the last 3 months, the mean price target is $5.65 with high estimates of $13.75 and low estimates of $3.00. In terms of 52-week highs and lows, CYH has a high of $14.74 and a low of $1.88.
As of this writing, CYH has an earnings estimate of $0.45 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $0.81 per share and a lower estimate of -$0.09. The company reported an EPS of -$2.52 in the last quarter, which was -6,400.00% lower than expectations of $0.04.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 12 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CYH is Hold with a score of 3.57. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 8 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.